PSNL (Personalis) Debt-to-Equity : 0.27 (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Personalis Debt-to-Equity?

Personalis's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $9.14 Mil. Personalis's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $36.01 Mil. Personalis's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $166.76 Mil. Personalis's debt to equity for the quarter that ended in Sep. 2024 was 0.27.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Personalis's Debt-to-Equity or its related term are showing as below:

PSNL' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.93 Med: 0.18 Max: 0.42
Current: 0.27

During the past 7 years, the highest Debt-to-Equity Ratio of Personalis was 0.42. The lowest was -0.93. And the median was 0.18.

PSNL's Debt-to-Equity is ranked worse than
50.26% of 191 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.27 vs PSNL: 0.27

Personalis Debt-to-Equity Historical Data

The historical data trend for Personalis's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Personalis Debt-to-Equity Chart

Personalis Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.02

0.06

0.19

0.22

0.37

Personalis Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial															0.31	0.37	0.39	0.42	0.27

Competitive Comparison of Personalis's Debt-to-Equity

For the Diagnostics & Research subindustry, Personalis's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Personalis's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Personalis's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Personalis's Debt-to-Equity falls into.

Personalis Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Personalis's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(9.407	+	38.321)	/	129.441
	=	0.37

Personalis's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(9.144	+	36.012)	/	166.761
	=	0.27

Personalis (NAS:PSNL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Personalis Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Personalis's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Personalis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Personalis Inc (NAS:PSNL) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

04X:Germany

Address

6600 Dumbarton Circle, Fremont, CA, USA, 94555

Website

https://www.personalis.com

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Executives

Richard Chen	officer: Chief Scientific Officer	C/O PERSONALIS, INC., 1330 O'BRIEN DRIVE, MENLO PARK CA 94025
Stephen Michael Moore	officer: General Counsel	C/O PERSONALIS, INC., 1330 O'BRIEN DRIVE, MENLO PARK CA 94025
Aaron Tachibana	officer: Chief Financial Officer	400 NORTH MCCARTHY BLVD, MILPITAS CA 95035
Christopher M Hall	officer: President	6600 DUMBARTON CIRCLE, FREMONT CA 94555
Myers Woodrow A Jr	director	1 N ILLINOIS SREET 2101, INDIANAPOLIS IN 46204
Kenneth J Widder	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Lonnie Shoff	director	C/O PERSONALIS, INC., 1330 O'BRIEN DRIVE, MENLO PARK CA 94025
John Stephen West	director, officer: President and CEO	C/O PERSONALIS, INC., 6600 DUMBARTON CIRCLE, FREMONT CA 94555
Lightspeed Venture Partners Select Iv, L.p.	other: Affiliate of 10% Owner	2200 SAND HILL ROAD, MENLO PARK CA 94025
Olivia Kyusuk Bloom	director	C/O GERON CORP, 230 CONSTITUTION DRIVE, MENLO PARK CA 94025
Llp Abingworth	10 percent owner	38 JERMYN STREET, LONDON X0 SW1Y 6DN
Ken Ludlum	director
Arif Janmohamed	other: Affiliate of 10% Owner	2200 SAND HILL ROAD, SUITE 100, MENLO PARK CA 94025
Lightspeed Ultimate General Partner Select Iv, L.l.c.	other: Affiliate of 10% Owner	2200 SAND HILL ROAD, SUITE 100, MENLO PARK CA 94025
Lightspeed General Partner Select Iv, L.p.	other: Affiliate of 10% Owner	2200 SAND HILL ROAD, SUITE 100, MENLO PARK CA 94025